IDO1 and urinary bladder carcinoma: To explore the underlying molecular mechanism of miR-153 in bladder cancer, we measured interleukin-6 (IL6) expression in supernatants of miR-153-overexpressing or IDO1 knocked down bladder cancer cells compared to the negative control cells.